InsiderTrades

Form 4 for HRMY Harmony Biosciences Holdings, Inc.

Accepted 2025-01-15 00:00:00 ET · period of report 2025-01-13 · accession 0001415889-25-001489 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-01-15 2025-01-13 HRMY Dierks Jeffrey Chief COMMERCIAL Off S - Sale+OE $37.04 -7,180 0 -100% -$265.9K
D 2025-01-15 2025-01-13 HRMY Dierks Jeffrey Chief COMMERCIAL Off M - OptEx $33.44 +7,180 7,180 New +$240.1K
D 2025-01-15 2025-01-13 HRMY Dierks Jeffrey Chief COMMERCIAL Off M - OptEx $0.00 -7,180 46.7K -13% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-13 S D 7,180 $37.04 0 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2 Common Common Stock 2025-01-13 M A 7,180 $33.44 7,180 D — —
3 Derivative Stock Option 2025-01-13 M D 7,180 $0.00 46,720 D $33.44 · — to 2031-06-01 7,180 Common Stock (F3) The stock option shall vest with respect to 50% of the underlying shares on June 1, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on July 1, 2023.